Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen.
A recently described technique for the polyclonal induction of plaque-forming cells from human bone-marrow derived (B) lymphocytes of peripheral blood has been used to assess the role of a human Ia-like antigen (p23,30) in differentiation of human B cells. In particular, the effects of antisera to p23,30 on the plaque-forming cells and proliferative responses of human B cells stimulated by pokeweed mitogen or soluble products of activated human thymus-derived lymphocytes (T cells) have been examined. Antisera to p23,30 eliminated the development of plaque-forming cells induced by both T cell products and pokeweed mitogen. While these antisera also abrogated B cell proliferation induced by T cell supernatants, the proliferative response generated by pokeweed mitogen was only partially reduced. It was also determined that while the p23,30 antigen continues to be expressed on fully differentiated plaque-forming cells, antisera to this determinant exert inhibitory effects on B cell differentiation only when present during the early stages of B cell cultures. These results lend further support to the analogy between p23,30 and murine Ia antigens. Moreover, they demonstrate a major role for this antigen in the early events involved in human B cell differentiation into antibody-forming cells.
D000937:Antigen-Antibody Reactions; D000941:Antigens; D001853:Bone Marrow / Q000276:immunology / Q000502:physiology*; D002478:Cells, Cultured; D006801:Humans; D007106:Immune Sera; D008214:Lymphocytes / Q000276:immunology / Q000502:physiology*
D000941:Antigens; D007106:Immune Sera
Science. 1963 Apr 26;140(3565):405
13957684
Transplant Rev. 1976;30:64-82
59979
J Exp Med. 1974 Dec 1;140(6):1717-22
4139236
Transplant Proc. 1973 Mar;5(1):377-81
4266664
J Exp Med. 1974 Oct 1;140(4):921-38
4610076
J Exp Med. 1976 Jul 1;144(1):98-112
58959
Transplant Rev. 1976;30:197-235
59973
J Exp Med. 1974 Nov 1;140(5):1303-16
4608321
J Immunol. 1974 Oct;113(4):1113-21
4547224
J Exp Med. 1976 Jul 1;144(1):113-22
1084400
J Exp Med. 1975 Jan 1;141(1):263-8
1090698
J Exp Med. 1975 Aug 1;142(2):460-72
1079849
J Exp Med. 1975 May 1;141(5):1201-9
1079233
Proc Soc Exp Biol Med. 1975 Nov;150(2):313-7
1082141
Science. 1975 Apr 18;188(4185):268-70
1118728